Andre G

Title : No additional benefit of HRT on response to rivastigmine in menopausal women with AD -

Author(s) : Rigaud AS , Andre G , Vellas B , Touchon J , Pere JJ

Ref : Neurology , 60 :148 , 2003

Title : [Oestro-progestagen treatment combined with rivastigmine in menopausal women suffering from Alzheimer's disease. The results of a 28-weeks controlled study] - Rigaud_2003_Presse.Med_32_1649

Author(s) : Rigaud AS , Andre G , Vellas B , Touchon J , Pere JJ , Loria-Kanza Y

Ref : Presse Med , 32 :1649 , 2003

Abstract : Rigaud_2003_Presse.Med_32_1649

ESTHER : Rigaud_2003_Presse.Med_32_1649

PubMedSearch : Rigaud_2003_Presse.Med_32_1649

PubMedID: 14631268

Andre G

References (2)

1. No additional benefit of HRT on response to rivastigmine in menopausal women with AD

2. [Oestro-progestagen treatment combined with rivastigmine in menopausal women suffering from Alzheimer's disease. The results of a 28-weeks controlled study]